Representative Lisa C. McClain (R-Michigan) recently bought shares of Colgate-Palmolive Company NYSE: CL. In a filing disclosed on August 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Colgate-Palmolive stock on June 17th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.
Representative Lisa C. McClain also recently made the following trade(s):
- Sold $1,001 - $15,000 in shares of Autoliv NYSE: ALV on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Applied Materials NASDAQ: AMAT on 8/4/2025.
- Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/4/2025.
- Sold $1,001 - $15,000 in shares of SAP NYSE: SAP on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of XPO NYSE: XPO on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of Lithia Motors NYSE: LAD on 7/22/2025.
- Sold $1,001 - $15,000 in shares of Sanofi NASDAQ: SNY on 7/22/2025.
- Sold $1,001 - $15,000 in shares of Waters NYSE: WAT on 7/22/2025.
- Purchased $1,001 - $15,000 in shares of Group 1 Automotive NYSE: GPI on 7/22/2025.
Colgate-Palmolive Stock Performance
NYSE CL traded down $1.5230 during trading on Monday, reaching $84.4170. The company's stock had a trading volume of 1,952,596 shares, compared to its average volume of 5,200,033. The company has a debt-to-equity ratio of 6.79, a quick ratio of 0.57 and a current ratio of 0.89. The firm has a market cap of $68.23 billion, a price-to-earnings ratio of 23.72, a P/E/G ratio of 4.47 and a beta of 0.35. Colgate-Palmolive Company has a twelve month low of $82.40 and a twelve month high of $109.30. The business's fifty day moving average price is $87.60 and its 200-day moving average price is $89.96.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same period in the previous year, the business posted $0.91 earnings per share. Colgate-Palmolive's quarterly revenue was up 1.0% on a year-over-year basis. As a group, analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.
Colgate-Palmolive Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were given a $0.52 dividend. The ex-dividend date of this dividend was Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive's payout ratio is 58.43%.
Wall Street Analyst Weigh In
Several analysts have issued reports on CL shares. Barclays upped their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a report on Tuesday, July 15th. Wall Street Zen downgraded shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. UBS Group reduced their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Finally, Wells Fargo & Company reduced their price objective on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. Seven research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $98.92.
Check Out Our Latest Report on Colgate-Palmolive
Institutional Investors Weigh In On Colgate-Palmolive
Several large investors have recently made changes to their positions in CL. Silverlake Wealth Management LLC increased its holdings in shares of Colgate-Palmolive by 9.6% in the 2nd quarter. Silverlake Wealth Management LLC now owns 3,472 shares of the company's stock worth $316,000 after acquiring an additional 304 shares during the period. Cim Investment Management Inc. raised its position in Colgate-Palmolive by 99.6% during the second quarter. Cim Investment Management Inc. now owns 15,927 shares of the company's stock valued at $1,448,000 after acquiring an additional 7,948 shares in the last quarter. Saratoga Research & Investment Management raised its position in Colgate-Palmolive by 1.1% during the second quarter. Saratoga Research & Investment Management now owns 195,696 shares of the company's stock valued at $17,789,000 after acquiring an additional 2,140 shares in the last quarter. Marex Group plc bought a new position in Colgate-Palmolive during the second quarter valued at approximately $334,000. Finally, Advisory Services Network LLC raised its position in shares of Colgate-Palmolive by 4.0% in the second quarter. Advisory Services Network LLC now owns 65,828 shares of the company's stock valued at $5,520,000 after purchasing an additional 2,529 shares during the period. Institutional investors and hedge funds own 80.41% of the company's stock.
About Representative McClain
Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.
McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election.
Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.
About Colgate-Palmolive
(
Get Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access